Profile for Alnylam Pharmaceuticals Inc. (ALNY)

$ 105.82   1.61 (+1.54%) Volume: 501.45k 4:00 PM EDT Apr 3, 2020
After Hours:  $ 105.82 0.00 (0.00%) Volume: 22.14k 5:04 PM EDT Apr 3, 2020
Business Description:
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
Address: 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, USA, 02142
Telephone: +1 617 551-8200 Website:
Facsimile: +1 617 551-8101 Email: N/A
CEO: John M. Maraganore
Employees: 1,323 Market Cap: 11.97b
Issue Type: CS
Auditor: PricewaterhouseCoopers LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1178670
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)